Japan, March 27 -- CELLDEX THERAPEUTICS INC has got intellectual property rights for 'ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS.' Other related details are as follows:

Application Number: JP,2024-019931

Category (FI): A61K39/395@N,A61K39/395@T,A61K39/395@U,A61P35/00,C07K16/28,C07K16/46,C12N15/13,C12N15/85@Z,C12N5/0783,C12P21/08

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Feb. 14, 2024

Publication Date: April 23, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....